How Does Short Selling Work? What You Need to Know

Nasdaq released a Short Selling Resource Hub and reiterated its support for greater transparency and disclosure around short positions, including when market participants publish negative research. The article outlines how short selling works, the risks of unlimited losses and margin calls, and the main U.S. safeguards under Reg SHO, including marking, locate, price-test, and close-out requirements. It is primarily educational and regulatory in nature, with limited near-term market impact.

Analysis

The practical takeaway for NDAQ is not the educational content itself, but the signaling function: Nasdaq is positioning as the venue owner that can monetize the politics of transparency, not just the matching engine. If short-interest disclosure becomes more granular, the exchange can gain incremental data-product revenue and more embedded relevance with regulators, while broker-dealers and prime brokers face higher compliance and operational costs. That shifts bargaining power modestly toward listed venues and away from the opaque over-the-counter economics of securities lending.

The second-order effect is that better short-position visibility tends to compress the payoff to activist shorts and research-driven short campaigns, especially those relying on speed and ambiguity rather than fundamentals. That is bullish for defensives and crowded quality names where short interest is often a catalyst for squeezes, but it also makes the market more efficient at unwinding weak balance-sheet stories before they become systemic. In other words, the loser is not “short sellers” broadly; it is leveraged shorts with poor borrow discipline and weak disclosure hygiene.

For NDAQ, the near-term catalyst is policy rather than volume: any SEC action on short-sale reporting or paired disclosure around negative research would be a multi-quarter narrative upgrade. The risk is that policymakers like the idea of transparency but stop short of mandatory disclosure, leaving Nasdaq with reputational wins but limited economic upside. On the other hand, if the next market selloff revives retail scrutiny of short selling, the probability of rulemaking rises meaningfully over the next 6-12 months.

The contrarian view is that this is not a tradable “short squeeze” catalyst for the broad market; it is a slow-burn regulatory drift that mainly affects positioning behavior at the margin. That means the best expression is not a momentum bet on a meme-style squeeze basket, but a relative-value position where the exchange benefits from any increase in data monetization and the brokers bear the friction. If transparency rises without a ban, the end state is usually better liquidity and more stable spreads, not a collapse in short activity.

Key Decisions for Investors

• Long NDAQ vs short ICE in a 3-6 month pair: NDAQ has cleaner upside to any short-disclosure/data-product regime, while ICE is less levered to this specific policy theme; target 5-8% relative outperformance if rulemaking headlines build.
• Buy NDAQ Jan-2026 calls on policy pullbacks: use 10-15% OTM strikes to express a low-beta regulatory upside skew; stop if no SEC movement emerges by the next 2 quarters.
• Short a basket of high-short-interest, low-float names only on catalyst windows, not outright: prefer defined-risk put spreads 30-60 days out to capture squeeze risk without unlimited borrow-driven pain.
• Avoid overweighting broker-dealers with heavy securities-lending dependence into any transparency headline cycle; if the market starts pricing more reporting friction, those names should underperform over 1-2 quarters.
• If the SEC opens a formal comment/reproposal process, rotate into NDAQ and out of short-enthused activist-exposed names for 4-8 weeks; the market typically overprices squeeze risk before the actual rule text matters.